Evidence map›Paper›PMID 32927700›Full record

ArticleCancers2020

Influence of Target Location, Size, and Patient Age on Normal Tissue Sparing- Proton and Photon Therapy in Paediatric Brain Tumour Patient-Specific Approach.

Mikaela Dell'Oro, Michala Short, Puthenparampil Wilson, Chia-Ho Hua, Melissa Gargone, Thomas E Merchant, Eva Bezak

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mikaela Dell'OroCancer Research Institute, University of South Australia, Adelaide SA 5001, Australia.ORCID 0000-0002-1459-1820
Michala ShortCancer Research Institute, University of South Australia, Adelaide SA 5001, Australia.ORCID 0000-0003-2249-3419
Puthenparampil WilsonDepartment of Radiation Oncology, Royal Adelaide Hospital, Adelaide SA 5000, Australia.
Chia-Ho HuaDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-6642-4004
Melissa GargoneDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Thomas E MerchantDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-0412-6255
Eva BezakCancer Research Institute, University of South Australia, Adelaide SA 5001, Australia.ORCID 0000-0002-1315-1735
St. Jude Children's Research Hospital · USRoyal Adelaide Hospital · AUUniversity of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProton radiotherapy produces superior dose distributions compared to photon radiotherapy, reducing side effects. Differences between the two modalities are not fully quantified in paediatric patients for various intracranial tumour sites or age. Understanding these differences may help clinicians estimate the benefit and improve referral across available centres. Our aim was to compare intensity-modulated proton therapy (IMPT) and intensity-modulated photon radiotherapy (IMRT) radiation doses for select paediatric intracranial tumours.

methodsIMPT and IMRT dose distributions for gender-matched paediatric cranial CT-datasets (ages 5, 9 and 13 years) were retrospectively calculated to simulate irradiation of supratentorial (ependymoma) and infratentorial (medulloblastoma) target volumes diameters (1-3 cm) and position (central and 1-2 cm shifts).

resultsClinical dosimetric objectives were achieved for all 216 treatment plans. Whilst infratentorial IMPT plans achieved greater maximum dose sparing to optic structures (4.8-12.6 Gy optic chiasm), brainstem sparing was limited (~0.5 Gy). Mean dose difference for optic chiasm was associated with medulloblastoma target position (

conclusionsNormal tissue sparing was achieved regardless of patient age for infratentorial tumours. However, for supratentorial tumours, there was a dosimetric advantage of IMPT across 9 vs. 13-year-old patients.

Indexed as

brain tumourIMPTIMRTnormal tissue sparingpaediatricpaediatric agepatient-specificproton therapytarget size and location

Identifiers

PMID32927700
PMCPMC7563785
OpenAlexW3083846063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.